Brain-Derived Neurotrophic Factor (BDNF) Acts Primarily via the JAK/STAT Pathway to Promote Neurite Growth in the Major Pelvic Ganglion of the Rat: Part 2
- 1 September 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 3 (5) , 821-829
- https://doi.org/10.1111/j.1743-6109.2006.00292.x
Abstract
Surgical and radiation therapies of bladder and prostate cancers may damage cavernous nerves and cause erectile dysfunction (ED). We previously showed that brain‐derived neurotrophic factor (BDNF) could restore erectile function in a neurogenic ED rat model. We now investigated the signaling mechanism of BDNF in major pelvic ganglia (MPG) explants. To identify the signaling mechanism that mediates the neurotrophic effect of BDNF in cultured MPG. Major pelvic ganglia was isolated from male rats for immunohistochemistry and immunofluorescence staining to locate BDNF receptors, pan‐neurotrophin 75 (p75), tropomyosin‐related kinase B (TrkB), and tropomyosin‐related kinase C (TrkC). The dorso‐caudal region of MPG was treated with BDNF to determine the optimal dosage for promoting neurite growth. Specific kinase inhibitors AG490, KT5720, LY294002, and U0126 were then used to treat MPG either alone or prior to BDNF treatment. The treated MPG was examined for neurite growth and for expression and phosphorylation of JAK2, STAT1, and STAT3 by Western blot analysis. Lengths of neurite growth from MPG were measured to quantify the effects of BDNF and to identify specific signaling pathways. Ratios of phosphorylated vs. unphosphoryated proteins of JAK2, STAT1, and STAT2 in control and treated MPG were determined to confirm JAK/STAT as the principal signaling pathway. Tropomyosin‐related kinase B and TrkC were localized to neurons whereas p75 to perineuronal satellite glial cells (SGC). The optimal dosage of BDNF for promoting MPG neurite growth was between 25 and 50 ng/mL. Among the four specific kinase inhibitors, AG490 was the strongest in suppressing MPG neurite growth as well as BDNF‐induced phosphorylation of JAK2, STAT1, and STAT3. In rat MPG, TrkB and TrkC were expressed in neurons, whereas p75 in SGC. Optimal BDNF dosage for promoting MPG neurite growth was between 25 and 50 ng/mL. BDNF promotes MPG neurite growth primarily by activating the JAK/STAT pathway. Lin G, Bella AJ, Lue TF, and Lin C‐S. Brain‐derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: Part 2. J Sex Med 2006;3:821–829.Keywords
Funding Information
- California Urology Foundation (2R01-DK-45370)
This publication has 24 references indexed in Scilit:
- Management of erectile dysfunction after radical prostatectomyUrology, 2005
- ORIGINAL RESEARCH—PHARMACOTHERAPY: Efficacy of Sildenafil Citrate in Men with Erectile Dysfunction Following Radical Prostatectomy: A Systematic Review of Clinical DataThe Journal of Sexual Medicine, 2005
- The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile FunctionThe Journal of Sexual Medicine, 2005
- Erectile Dysfunction Following Radical ProstatectomyJAMA, 2005
- Incontinence and Erectile Dysfunction Following Radical Prostatectomy: A ReviewThe Scientific World Journal, 2005
- The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injuryBJU International, 2004
- Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablationInternational Journal Of Impotence Research, 2004
- The effect of vascular endothelial growth factor and brain‐derived neurotrophic factor on cavernosal nerve regeneration in a nerve‐crush rat modelBJU International, 2003
- THE EFFECT OF ADENO-ASSOCIATED VIRUS MEDIATED BRAIN DERIVED NEUROTROPHIC FACTOR IN AN ANIMAL MODEL OF NEUROGENIC IMPOTENCEJournal of Urology, 2001
- Sympathetic pathways and adrenergic innervation of the penisInternational Journal Of Impotence Research, 2000